ENTEROSGEL® was developed in 1980-s and has been available as an over-the-counter treatment since 1996 in other countries. Since then millions of patients have been using ENTEROSGEL®. Over 20,000 patients have been studied during the post-marketing IIT (investigators initiated trials) in other countries.
100 doses of ENTEROSGEL® per second are taken in the world. 8 millions tubes are sold last year in Europe. During this time there have been no reported incidences of over dosage, systemic side effects or adverse reactions related to use of ENTEROSGEL®.